Apparatus and method for analysis of molecules

• US 7,302,146 B2
• Filed: 09/16/2005
• Issued: 11/27/2007
• Est. Priority Date: 09/17/2004
• Status: Active Grant

• Current Assignee: Pacific Bioscience of California Incorporated (L'Oreal SA)
• Original Assignee: Pacific Bioscience of California Incorporated (L'Oreal SA)
• Inventors: Turner, Stephen, Korlach, Jonas
• Primary Examiner(s): Wells; Nikita
• Application Number:
  US11/228,925
• Publication Number:
  US 20060061755A1
• Time in Patent Office: 802 Days
• Field of Search: None
• US Class Current: 385/123
• CPC Class Codes: B01L 2200/0668 Trapping microscopic beads
• CPC Class Codes: B01L 2300/0654 Lenses; Optical fibres
• CPC Class Codes: B01L 2300/0896 Nanoscaled
• CPC Class Codes: B01L 3/5085 for multiple samples, e.g. microtitration plates
• CPC Class Codes: B82Y 20/00 Nanooptics, e.g. quantum optics or photonic crystals
• CPC Class Codes: B82Y 30/00 Nanotechnology for materials or surface science, e.g. nanocomposites
• CPC Class Codes: C12Q 1/6869 Methods for sequencing
• CPC Class Codes: C12Q 2521/101 DNA polymerase
• CPC Class Codes: C12Q 2521/543 Immobilised enzyme(s)
• CPC Class Codes: C12Q 2561/113 Real time assay
• CPC Class Codes: C12Q 2565/537 characterised by the capture oligonucleotide acting as a primer
• CPC Class Codes: G01N 21/6452 Individual samples arranged in a regular 2D-array, e.g. multiwell plates
• CPC Class Codes: G02B 6/13 Integrated optical circuits characterised by the manufacturing method
• CPC Class Codes: Y10T 436/10 Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing

Abstract

The present invention relates to optical confinements, methods of preparing and methods of using them for analyzing molecules and/or monitoring chemical reactions. The apparatus and methods embodied in the present invention are particularly useful for high-throughput and low-cost single-molecular analysis.

Claims

1. An apparatus comprising:

an array of optical confinements having a density on a substrate exceeding 4×

10⁴ confinements per mm², wherein said optical confinements are suitable for holding a biological reagent, and wherein said optical confinements provide an effective observation volume that permits observation of individual molecules present in said biological reagent; and

an optical system operatively coupled to the optical confinements that detects signals from the effective observation volume of said confinements.

2. The apparatus of claim 1, wherein said density exceeds 10⁵ confinements per mm².

3. The apparatus of claim 1 or 2, wherein said optical confinements hold a biological reagent.

4. The apparatus of claim 3, wherein said biological reagent comprises an enzyme.

5. The apparatus of claim 3, wherein said biological reagent further comprises substrates of said enzyme present at a concentration of about Michaelis constant (Km) of said enzyme for said substrates.

6. The apparatus of claim 5, wherein said concentration is higher than about 1 micromolar.

7. The apparatus of claim 5, wherein said concentration is higher than about 50 micromolar.

8. The apparatus of claim 5, wherein said substrates are labeled.

9. The apparatus of claim 5, wherein said individual molecules are products of a reaction between said enzyme and said substrates contained in said biological reagent.

10. The apparatus of claim 3, wherein said individual molecules are DNA/polymerase complexes.

11. The apparatus of claim 3, wherein said individual molecules are biomolecules selected from the group consisting of nucleic acids, polypeptides, and combinations thereof.

12. The apparatus of claim 3, wherein said individual molecules are organic or inorganic chemical compounds.

13. The apparatus of claim 3, wherein at least one individual confinement is separated from at least one other optical confinement in said array by a distance less than about 1000 nm.

14. The apparatus of claim 3, wherein said optical confinements in said array are separated from each other by a distance between about 200 nm and about 1000 nm.

15. The apparatus of claim 3, wherein said array comprises at least about 2×

10⁵ optical confinements.

16. The apparatus of claim 3, wherein said array comprises at least about 10⁷ optical confinements.

17. The apparatus of claim 3, wherein said individual molecules are labeled with a detectable label.

18. The apparatus of claim 17, wherein said detectable label is selected from the group consisting of a fluorescent label, a chemiluminescent label, and a radioactive label.

19. The apparatus of claim 3, wherein said optical confinements are made of porous film.

20. The apparatus of claim 3, wherein each individual confinement in said array is operatively coupled to an optical transmission element transmitting an incident light.

21. The apparatus of claim 3, wherein said optical system further comprises a photon detector.

22. The apparatus of claim 3, wherein said optical confinements are waveguides comprising a cladding surrounding a core, wherein said cladding precludes propagation of a majority of incident light having a wavelength greater than a cutoff wavelength through said core.

23. The apparatus of claim 22, wherein said waveguides preclude propagation of more than 90% of incident light having a wavelength greater than a cutoff wavelength through said core.

24. The apparatus of claim 22, wherein said waveguides preclude propagation of more than 99% of incident light having a wavelength greater than a cutoff wavelength through said core.

25. The apparatus of claim 22, wherein said cladding comprises a sheet, and one or more holes extending through said sheet where each hole constitutes the core.

26. The apparatus of claim 22, wherein said core is cylindrical in shape.

27. The apparatus of claim 22, wherein said core is non-cylindrical in shape.

28. The apparatus of claim 22, wherein said cladding comprises a metal alloy.

29. The apparatus of claim 28, wherein said alloy is aluminum alloy.

30. The apparatus of claim 3, wherein each individual confinement provides an effective observation volume less than about 1000 zeptoliters.

31. The apparatus of claim 3, wherein each individual confinement provides an effective observation volume less than about 80 zeptoliters.

32. The apparatus of claim 3, wherein each individual confinement provides an effective observation volume less than about 10 zeptoliters.

33. A kit comprising an array of optical confinements of claim 3 and an instruction manual for use of said array.

34. The apparatus of claim 3, wherein a plurality of said optical confinements in said array each holds a single complex of a target nucleic acid and a polymerization enzyme, and more than one type of labeled nucleotides or nucleotide analogs present at a concentration about 1 uM to about 50 uM.

35. The apparatus of claim 34, wherein said optical confinements are zero-mode waveguides.

36. A method of performing multiple chemical reactions involving a plurality of reaction samples, comprising:

(a) providing an array of optical confinements of claim 1;

(b) placing the plurality of reaction samples comprising labeled reactants into the optical confinements in the array, wherein a separate reaction sample is placed into a different confinement in the array;

(c) subjecting the array to conditions suitable for formation of products of the chemical reactions; and

(d) detecting the formation of the products with said optical system.

37. The method of claim 36, wherein the step of detecting comprises illuminating the different confinements with an incident light beam and detecting an optical signal emitted from the reaction samples.

38. The method of claim 36, wherein the chemical reactions involve protein-protein interactions.

39. The method of claim 36, wherein the chemical reactions involve nucleic acid-protein interactions.

40. The method of claim 36, wherein the chemical reactions involve nucleic acid-nucleic acid interactions.

41. A method of detecting a biological analyte, comprising:

optically capturing the analyte within an optical confinement that is created by

(a) providing an array of optical confinements having a density on a substrate exceeding 4×

10⁴ confinements per mm², wherein said optical confinements provide an effective observation volume that permits observation of individual molecules; and

an optical system operatively coupled to the optical confinements that detects signals from the effective observation volume of said confinements; and

(b) illuminating at least one optical confinement within the array that is suspected to contain the analyte with an incident light beam thereby detecting the analyte.

42. The method of claim 41, wherein said density on a substrate exceeding 10⁵ confinements per mm².

43. The method of claim 41, wherein said analyte is labeled with a detectable label.

44. The method of claim 41, wherein said analyte is selected from the group consisting of nucleic acid, polypeptide, organic compound, and inorganic compound.

45. A method of sequencing a plurality of target nucleic acid molecules, comprising:

(a) providing an array of optical confinements having a density on a substrate exceeding 4×

10⁴ confinements per mm², wherein said optical confinements provide an effective observation volume that permits observation of individual molecules; and

an optical system operatively coupled to the optical confinements that detects signals from the effective observation volume of said confinement;

(b) mixing in the optical confinements the plurality of target nucleic acid molecules, primers complementary to the target nucleic acid molecules, polymerization enzymes, and more than one type of nucleotides or nucleotide analogs to be incorporated into a plurality of nascent nucleotide strands, each strand being complementary to a respective target nucleic acid molecule;

(c) subjecting the mixture of step (b) to a polymerization reaction under conditions suitable for formation of the nascent nucleotide strands by template-directed polymerization of the nucleotides or nucleotide analogs;

(d) illuminating the optical confinements with an incident light beam; and

(e) identifying the nucleotides or the nucleotide analogs incorporated into the each nascent nucleotide strand.

46. The method of claim 45, wherein the step of identifying yields a time sequence of incorporation of the nucleotides provided in step (b).

47. The method of claim 45, wherein the identifying step is effected while the template-directed polymerization is taking place.

48. The method of claim 45, wherein the target nucleic acid molecules are selected from the group consisting of circular DNA molecules, linear DNA molecules, RNA molecules, and DNA/RNA hybrids.